Profiles
Scopus
ORCID
📍Current Position
Dr. Maria Julia Montoro Gómez is currently a Consultant in Haematology at the Hospital Universitari Vall d’Hebron in Barcelona, Catalonia, Spain. Since June 2013, she has been serving at this esteemed institution, where she focuses on myelodysplastic syndromes (MDS). Her professional category at the Institut Català de la Salut underscores her commitment to clinical hematology and therapeutic interventions. Dr. Montoro also plays a leadership role in the Hematological Genetic Counseling Unit, coordinating services for patients with Myeloid Neoplasms.
📝Publication Achievements
With a passion for advancing research in hematology, Dr. Montoro has contributed significantly to the scientific community. She has a total of 27 publications, most of which are published in top-tier journals, including some in the first quartile and three in the first decile. Her work has been widely recognized, with over 315 citations and an H-index of 10, a remarkable achievement in the medical field. Two of her most notable publications came from her Ph.D. thesis, which earned the distinction of Cum Laude in 2019.
🔍Ongoing Research
Dr. Montoro’s ongoing research efforts continue to focus on myelodysplastic syndromes (MDS) and related hematologic conditions. In particular, her work delves into the molecular mechanisms of disease and therapeutic interventions. She has been part of cutting-edge studies on the prediction of response to lusparcept in MDS, collaborating with international leaders like Dr. Raza at the Herbert Irving Cancer Center, Columbia University. Dr. Montoro’s research aims to develop better strategies for prognostic evaluation and treatment personalization for patients with MDS.
🔬 Research Interests
Her key research interests lie in clinical medicine, therapeutics, healthcare, and the molecular mechanisms underlying disease progression in myeloid neoplasms. Specifically, Dr. Montoro is committed to finding better prognostic markers and treatment responses in hematological disorders. In addition, her interest in the genetics of hematological diseases is reflected in her role as the coordinator of the Hematological Genetic Counseling Unit at Vall d’Hebron.
🎓Academic Background
Dr. Montoro’s journey in medicine began with a Bachelor’s degree in Medicine and Surgery from the Universitat de València in 2008. She then completed her residency in Hematology and Hemotherapy at the Vall d’Hebron University Hospital from 2009 to 2013. Her academic excellence continued with a Ph.D. in Health Sciences from the Universitat Autònoma de Barcelona, where she defended her thesis titled “Improving strategies for the prognostic evaluation of Myelodysplastic Syndromes” with distinction. Dr. Montoro also pursued postgraduate studies in multiple linear regression at the Universitat Autònoma de Barcelona.
🏆Scholarships and Awards
Throughout her career, Dr. Montoro has earned several prestigious scholarships and grants. She was awarded the Research Promotion Grant from the Spanish Foundation of Hematology and Hemotherapy consecutively in 2014 and 2015 for her project on the impact of autoimmune disorders in MDS patients. Additionally, she received a grant from the CRIS Foundation for her innovative research at Columbia University on terminal erythroid differentiation.
🧬Bioinformatics
Dr. Montoro’s work incorporates advanced bioinformatics methodologies, especially in projects involving RNA sequencing and ex vivo systems to analyze cellular differentiation in MDS. These techniques are central to her research into predicting treatment responses and further advancing her understanding of the molecular mechanisms of these diseases.
🌐Professional Associations
Dr. Montoro is a proud member of several leading hematology organizations, including the Vall d’Hebron Institute of Oncology (VHIO), the Spanish Society of Hematology and Hemotherapy (SEHH), the European Society of Hematology (EHA), and the Spanish Group of Myelodysplastic Syndromes (GESMD). Her active participation in these groups helps her stay at the forefront of new developments in oncology and hematology.
📚Training & Workshops
Dr. Montoro has an extensive portfolio of workshops and training sessions, including the V Jornadas de Investigadores del Grupo Andaluz de Síndromes Mielodisplásicos and the 3ª Edición: Next Generation Diagnosis in Leukemia, where she shared her expertise on hematologic neoplasms. She has also participated in various national and international congresses, presenting her research findings both as a principal author and co-author.
🎤Oral Presentations and🗣️Thought Leadership
Throughout her career, Dr. Montoro has delivered 26 communications as a co-author and 10 as the principal author. Her oral presentations have addressed pivotal topics in myelodysplastic syndromes and have been well received at major conferences and workshops, further establishing her as a respected voice in the field.
🧑🔬Tasks Completed as a Researcher
As a researcher, Dr. Montoro has completed a variety of tasks, from conducting clinical studies to engaging in translational research. She has led numerous projects focused on myelodysplastic syndromes, coordinated multicenter studies, and collaborated with international experts on innovative treatments.
🚀Success Factors
Her success stems from a deep commitment to improving patient outcomes through a combination of clinical expertise and cutting-edge research. Dr. Montoro’s collaborative approach, combined with her drive to uncover the genetic basis of hematologic diseases, has solidified her reputation as a leader in her field.
🧪Publications & Laboratory Experience
Dr. Montoro’s laboratory experience includes significant work on cellular differentiation and molecular diagnostics in MDS. Her research has been published in top-tier journals, and her hands-on lab work has contributed to better prognostic evaluation strategies for MDS patients.
🔍 Conclusion
Dr. Maria Julia Montoro Gómez has had an exceptional career as an oncohematologist, with her research on myelodysplastic syndromes marking her as a leader in the field. Her dedication to both clinical practice and scientific research has earned her numerous awards, a strong presence in professional associations, and a prominent reputation in bioinformatics-driven medicine. Through her publications, presentations, and ongoing research, Dr. Montoro continues to make meaningful strides in improving patient outcomes and shaping the future of hematological care.
Publications